Moreover, the level of HOTAIR continually increased in prostate cancer cell lines upon treatment with enzalutamide (96), suggesting HOTAIR might serve as a biomarker indicating resistance against enzalutamide. The gene discussed is HOTAIR; the disease is Familial prostate cancer.